Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

被引：0

作者：

Kaniz Afroz Tanni

Cong Bang Truong

Sura Almahasis

Jingjing Qian

机构：

[1] Auburn University Harrison School of Pharmacy,Department of Health Outcomes Research and Policy

来源：

BioDrugs | 2021年 / 35卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：239 / 254

页数：15

共 50 条

[1] Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Tanni, Kaniz Afroz
Truong, Cong Bang
Almahasis, Sura
Qian, Jingjing
[J]. BIODRUGS, 2021, 35 (02) : 239 - 254
[2] Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
Putzke, Joerg
Haughie, Scott
Zou, Kelly H.
Ranganna, Gopinath M.
[J]. BIODRUGS, 2021, 35 (03) : 373 - 374
[3] Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
Joerg Putzke
Scott Haughie
Kelly H. Zou
Gopinath M. Ranganna
[J]. BioDrugs, 2021, 35 : 373 - 374
[4] Author’s Reply to Joerg Putzke et al. Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
Jingjing Qian
Cong Bang Truong
Kaniz Afroz Tanni
[J]. BioDrugs, 2021, 35 : 375 - 377
[5] Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
Qian, Jingjing
Truong, Cong Bang
Tanni, Kaniz Afroz
[J]. BIODRUGS, 2021, 35 (03) : 375 - 377
[6] Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database
Xue, Xiangzhong
Qian, Jingjing
[J]. EXPERT OPINION ON DRUG SAFETY, 2024,
[7] Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Subeesh, Viswam
Maheswari, Eswaran
Singh, Hemendra
Beulah, Thomas Elsa
Swaroop, Ann Mary
[J]. CURRENT DRUG SAFETY, 2019, 14 (01) : 21 - 26
[8] Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
Christodoulos, Iole N.
Chyou, Te-yuan
Nishtala, Prasad S.
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (12) : 1775 - 1776
[9] Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
Iole N. Christodoulos
Te-yuan Chyou
Prasad S. Nishtala
[J]. European Journal of Clinical Pharmacology, 2020, 76 : 1775 - 1776
[10] Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database
Chen, Jinhua
Yu, Weijiang
Zhang, Wancun
Sun, Cuicui
Zhang, Wenzhou
[J]. EXPERT OPINION ON DRUG SAFETY, 2024,

← 1 2 3 4 5 →